Federal Register / Vol. 66, No. 36 / Thursday, February 22, 2001 / Notices 11171

1Copies of the Minutes of the Federal Open

Market Committee meeting of January 3, 2001,

which include the domestic policy directive issued

at that meeting, are available upon request to the

Board of Governors of the Federal Reserve System,

Washington, D.C. 20551. The minutes are published

in the Federal Reserve Bulletin and in the Board’s

annual report.

By order of the Federal Open Market

Committee, February 2, 2001.

Donald L. Kohn,

Secretary, Federal Open Market Committee.

[FR Doc. 01–4338 Field 2–21–01; 8:45 am]

BILLING CODE 6210–01–S

FEDERAL RESERVE SYSTEM

Federal Open Market Committee;

Domestic Policy Directive of January 3,

2001

In accordance with § 71.5 of its rules

regarding availability of information (12

CFR part 271), there is set forth below

the domestic policy directive issued by

the Federal Open Market Committee at

its meeting held on January 3, 2001.1

The Federal Open Market Committee

seeks monetary and financial conditions

that will foster price stability and

promote sustainable growth in output.

To further its long-run objectives, the

Committee in the immediate future

seeks conditions in reserve markets

consistent with a reduction of the

federal funds rate to an average of

around 6 percent.

By order of the Federal Open Market

Committee, February 2, 2001.

Donald L. Kohn,

Secretary, Federal Open Market Committee.

[FR Doc. 01–4339 Field 2–21–01; 8:45 am]

BILLING CODE 6210–01–S

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Agency for Healthcare Research and

Quality (AHRQ)

Statement of Organization, Functions,

and Delegations of Authority

Part E, Chapter E (Agency for

Healthcare Research and Quality), of the

Statement of Organization, Functions,

and Delegations of Authority for the

Department of Health and Human

Services (61 FR 15955–58, April 10,

1996, most recently amended at 66 FR

7653 on January 24, 2001) is further

amended as follows:

Under Section E–20. Functions:

A. Within the statement for the

Division of Human Resource

Management (EAA6):

1. Delete ‘‘and organization’’ in the

first sentence;

2. Insert ‘‘and’’ before (3); and

3. Delete (4) and (5).

B. Delete the title and statement for

the Division of Research Synthesis and

Translation (EAF4); and

C. Delete the title and statement for

the Division of User Liaison (EAF5) and

replace with the following:

Division of User Liaison and Research

Translation (EAF5). Facilitates the

synthesis, translation, and

dissemination of existing research

findings, data and activities—

particularly in research areas to which

AHRQ has made substantial

contributions—to selected AHRQ

stakeholders. Specifically: (1)

Coordinates and supports development

of speeches and other presentations

made by the AHRQ Director; (2)

develops research syntheses focused on

issues of importance to health systems

administrators, large health care

purchasers, State and local health

policymakers, and others interested in

health services research; (3) plans and

conducts workshops and seminars to

provide research findings and related

information to State and local health

policymakers to allow them to make

better informed health care policy

decisions; (4) drafts articles, briefing

sheets, and other analytic documents

that synthesize and analyze particular

topics and issues in health services

research or pertaining to agency

activities; (5) coordinates and supports

ongoing improvement and maintenance

of the Agency’s research database

system; (6) maintains liaison with State

and local government organizations,

public policy organizations, and with

the research community and receives

and appropriately transmits information

which may impact the Agency’s

research plan and priority setting

process; and (7) develops and

implements mechanisms to identify and

contact potential users of research

findings and related information.

These changes are effective upon date

of signature.

Dated: February 12, 2001.

John M. Eisenberg,

Director.

[FR Doc. 01–4375 Filed 2–21–01; 8:45 am]

BILLING CODE 4160–90–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Disease, Disability, and Injury

Prevention and Control Special

Emphasis Panel (SEP): Competitive

Supplemental Funds For

Comprehensive STD Prevention

Systems: Monitoring STD Prevalence

and Reproductive Health Services For

Adolescent Women in Special Settings

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following meeting.

Name: Disease, Disability, and Injury

Prevention and Control Special Emphasis

Panel (SEP): Competitive Supplemental

Funds For Comprehensive STD Prevention

Systems: Monitoring STD Prevalence and

Reproductive Health Services For Adolescent

Women in Special Settings, Program

Announcement #99000–K, meeting.

Times and Date: 9 a.m.–9:30 a.m., March

8, 2001 (Open).

9:30 a.m.–4:30 p.m., March 8, 2001

(Closed).

Place: National Center for HIV, STD, and

TB Prevention, CDC, 8 Corporate Square

Blvd, Conference Room 1A, Atlanta, Georgia

30329.

Status: Portions of the meeting will be

closed to the public in accordance with

provisions set forth in section 552b(c)(4) and

(6), Title 5 U.S.C., and the Determination of

the Deputy Director for Program

Management, CDC, pursuant to Public Law

92–463.

Matters To Be Discussed: The meeting will

include the review, discussion, and

evaluation of applications received in

response to Program Announcement #99000–

K.

Contact Person for More Information:

Elizabeth A. Wolfe, Prevention Support

Office, National Center for HIV, STD, and TB

Prevention, CDC, Corporate Square Office

Park, 8 Corporate Square Boulevard, M/S

E07, Atlanta, Georgia 30329, telephone 404/

639–8025.

The Director, Management Analysis

and Services office has been delegated

the authority to sign Federal Register

notices pertaining to announcements of

meetings and other committee

management activities, for both the

Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: February 14, 2001.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention CDC.

[FR Doc. 01–4364 Filed 2–21–01; 8:45 am]

BILLING CODE 4163–18–P